Cardinal Health earnings beat by $0.31, revenue topped estimates

Cardinal Health (CAH) raised its FY26 adjusted EPS guidance to $12.80-$13.00 from $12.40-$12.60, citing strong Q1 performance. Shares closed at $261.93, up 3.55%.

Cardinal Health (NYSE:CAH) reported Q1 earnings of $3.26 per share, beating estimates by $0.31, with revenue up 5% YoY to $67.5B. The company raised its FY2027 EPS guidance to $12.80-$13.00. Shares rose 2.70% in pre-market trading. Growth was driven by the Pharmaceutical and Specialty Solutions segment, with revenue up 6% and profit up 17%.

Cardinal Health (CAH) reported fiscal Q1 net income of $554M, or $2.38 per share, beating analyst expectations of $2.92 per share. Revenue was $67.51B, exceeding forecasts of $66.96B. The company expects full-year earnings between $12.80 and $13 per share. CAH shares have risen 27% YTD and 34% over the past year.

CARDINAL HEALTH INC (CAH) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE Cardinal Health Reports First Quarter Fiscal Year 2027 Results and Raises Outlook • First quarter revenue increased 5% to $67.5 billion • GAAP 1 operating earnings increased 13% to $753 million; GAAP diluted EPS increased 27% to $2.38 • Non-GAAP

Cardinal Health (CAH) reported Q1 non-GAAP EPS of $3.26, beating estimates by $0.32, with revenue of $67.5B, up 5.5% year-over-year and exceeding expectations by $990M. The company raised its fiscal year 2027 non-GAAP EPS guidance to $12.80-$13.00, above the consensus of $12.56.

Cardinal Health reported Q1 2027 adjusted EPS of $3.26, beating estimates by 11%. Revenue was $67.51B, up 5.5% YoY. The company secured a deal with CVS Health and raised fiscal 2027 EPS guidance to $12.80-$13.00. Management also completed a $500M share repurchase program.